FDA-approved protease inhibitor used to treat HIV infection.
A protease inhibitor that is taken three times or twice daily, with food; approved for children and adults. Most common side effect is diarrhoea. Neonate: An infant at any time during the first four weeks of life. Neoplasm: An abnormal and uncontrolled growth of tissue; a tumour. Nephrolithiasis: Kidney stones. Neuropathy: Damage to the peripheral nerves; usually manifests as pain, tingling, or numbness in the feet or, more rarely, the hands. Drugs or HIV itself may cause neuropathy. Many treatments are used for this condition. Neutropenia: A condition where a person's white blood count is abnormally low, making him/her susceptible to bacterial infections. Neutropenia can be detected with a blood test. Neutrophil: A type of white blood cell important in fighting bacterial and fungal infections.
a protease inhibitor (trade name Viracept) used in treating HIV usually in combination with other drugs
a protease inhibitor drug currently in clinical trials.
a PROTEASE INHIBITOR from Agouron / Pfizer, FDA-approved for adults and children over two years old. Nelfinavir should be taken two or three times a day with a meal or light snack. Its most common SIDE EFFECT is diarrhea. Nelfinavir can reduce blood levels of oral contraceptives and increase blood levels of other protease inhibitors.
An FDA approved (03/14/97) protease inhibitor for the treatment of HIV infection when antiretroviral therapy is warranted in adults and children 2 years of age and older. Also called Viracept.
Indications: Treatment of HIV infection in combination with other agents. Contraindications: Known hypersensitivity. Dosage: 1250 mg po bid or 750 mg po tid with food. There are many potential drug interactions, some of which require dosage modification; see Physicians Desk Reference or package insert for more information. Toxicity: Diarrhea. Pregnancy category B.
Protease inhibitor used in combination with other antiretroviral agents for the treatment of HIV infection; also known as NFV. Generic name for Viracept®.
Nelfinavir (Viracept®) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV). Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is generally used in combination with other antiretroviral drugs. Nelfinavir is presented as the mesilate (mesylate) ester prodrug.
